skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Role of human beta defensin 3 during type I interferon mediated antiviral response against vesicular stomatitis virus

Original Research

(2181) Views  (907) Full article downloads

Authors: Mausumi Basu, Srikanth Kota, Amiya K Banerjee, et al

Published Date March 2010 Volume 2010:2 Pages 23 - 32
DOI: http://dx.doi.org/10.2147/IJICMR.S6799

Mausumi Basu2, Srikanth Kota1, Amiya K Banerjee2, Santanu Bose1

1Department of Microbiology and Immunology, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; 2Department of Molecular Genetics, Section of Virology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA

Abstract: Type I interferons (IFN), IFN-α/β constitute a critical component of innate immunity against viruses. IFN-α/β activates JAK/STAT pathway resulting in expression of various IFNstimulated antiviral proteins. While studying IFN-α/β signaling during virus infection, we identified human beta defensin-3 (HBD3) as an antiviral factor induced during IFN-α−mediated innate antiviral response in human lung epithelial cells. We showed that HBD3 is induced by IFN-α and purified HBD3 significantly inhibited vesicular stomatitis virus (VSV) infection. Further studies revealed that HBD3 confers its antiviral activity by blocking VSV cellular entry. An essential role of HBD3 during innate antiviral response was evident from loss of antiviral activity of IFN-α following HBD3 silencing by siRNA. Thus, we have identified HBD3 as an IFN-inducible antiviral factor that inhibits infection by blocking viral cellular entry.

Keywords: innate immunity, type I interferon, human beta defensin, virus infection








Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Endotoxin-induced IL-6 promoter activation in skeletal muscle requires an NF-κB site
Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection
Vesicular stomatitis virus modified with single chain IL-23 exhibits oncolytic activity against tumor cells in vitro and in vivo
Does smoking really protect from recurrent aphthous stomatitis?
Methemoglobinemia due to topical pharyngeal anesthesia during endoscopic procedures
Perception of risk and benefit in patient-centered communication and care
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Zinc oxide nanoparticles as selective killers of proliferating cells
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy